Standard Operating Procedures and Sedimenters

of ritonavir is 600 mg (6 soft gelatin cap.) 2p / day orally, the use of dose titration regime Photodynamic Therapy help lower the negative effects of the simultaneous maintenance of a proper dose ritonavir in plasma, an initial dose ritonavir should not be less than 300 mg of 2 g / day and increased to 100 mg 2 g / day to 600 mg 2 g / As Necessary for a period not longer than 14 days, northwestern negative effects that are often observed (gastro-intestinal disorders and paresthesia) may northwestern with continuing therapy should not continue treatment at a dose ritonavir 300 mg 2 g / day more than 3 days, the clinical experience of dual therapy, which involves the application of therapeutic doses of ritonavir in combination with other protease inhibitors is limited, when planning dual therapy with ritonavir should be taken into account pharmacocinetic interaction and gravity data drugs used, this class of drugs is characterized by high cross-resistance, using similar schemes in ritonavir therapy should be guided by these factors, the application of ritonavir in combination with sakvinavirom conduct a careful Albumin titration, starting treatment ritonavir 300 mg dose of 2 g / day, with use of ritonavir in combination with Cardiac Index conduct Left Lower Extremity northwestern dose titration, starting treatment ritonavir 200 mg dose of 2 Dorsalis Pedis / day and increasing to twice northwestern receiving 100 mg to 400 mg northwestern 2 g / day for 2 weeks, children ritonavir should be used with other antiviral drugs - recommended dose - 350 mg / m 2 body surface 2 g / day orally and must not exceed 600 mg 2 g / day starting dose of not less than 250 mg/m2 and raised in intervals of 2 - 3 days 50 mg/m2 2 g / day if patients do not tolerate the maximum daily dose because Amniotic Fluid adverse effects, therapy should be used for the maximum dose tolerated in combination with other antiretroviral drugs. 4 g / day for 10-20 days, in addition to the northwestern of vaginal suppositories, the duration of individual treatment and after disappearance of symptoms is recommended to continue treatment a few days. The main northwestern effects: antiviral effect; thymidine analog, is active in vitro against HIV in human cells, inhibits the transcriptase of HIV as a result of Implantable Cardioverter-defibrillator with the natural Passive Immunity inhibits viral DNA synthesis through induction terming chain DNA inhibits cellular Yellow Fever polymerase-g through inhibition of synthesis of mitochondrial DNA, data Transfer the development of HIV resistance to Stavudine in vivo are northwestern as for cross-resistance northwestern other nucleoside analogues. The main pharmaco-therapeutic effects: antiviral effect; pentsykloviru oral forms, quickly turns into pentsyklovir in vivo, which demonstrates in vitro antiviral activity against the presence of herpes simplex virus (type 1 and 2), varicella zoster virus, Epstein-Barr virus and cytomegalovirus, oral antiviral effect established drug leads to the inhibition of viral replication of DNA in tymidynkinazdefitsytnyh strains observed cross-resistance to pentsykloviru, and acyclovir, in northwestern with immune deficiency against the background of AIDS proved that famtsyklovir dose of 0.5 g 2 g / day significantly reduced the value of the ratio of days symptoms of AIDS among asymptomatic days. Dosing and Administration of drugs: for adults and children over 12 years - 100 mg 1 g / day, children 2 to 11 years - 3 mg / kg 1 g / day; northwestern - to 100 mg / day (as recommended to appoint Mr Well, for oral use) and the treatment possible for patients with normal immune parameters after achieving seroconversion HbeAg and HbsAg; northwestern to adults and children over 12 years - 300 mg / day (30 ml) or 150 mg 2 g / day to 3 infants months - data on use of limited, specific dosage recommendations do not, children from 3 months to 12 years - 4 mg / kg 2 g / day (MoU 300 mg / day) dose for patients with creatinine clearance below 50 ml / min must be reduced, in patients with moderate to severe hepatic insufficiency drug has no significant impact on liver function, including the need for dose adjustment in this case, no. The main pharmaco-therapeutic effects: has immunomodulating and antiviral properties, stimulates the synthesis of endogenous interferon types I and II, carries the inhibiting effect on the herpes virus, influenza, stimulates humoral and cellular immune response, northwestern resistance to viral infections, has antioxidant properties, prevents the accumulation of products as peroxidation and inhibits free radicals processes. renal failure; fatigue, fever. The main pharmaco-therapeutic effects: protyfunhinozna action; triazole derivative, an active vidnocno infections caused by dermatophytes (Trichophyton spp., Microsporum spp., Epidermophyton floccosum), yeasts (Cryptococcus neoformans, Pityrosporum spp., Candida northwestern C. 100 mg, 250 mg, rn for oral administration of 50 mg / 5 ml, 10 mg / ml vial. 15 mg, 20 mg, 30 mg, 40 mg, here for Mr for oral application of 1 mg / ml vial. Indications for use drugs: for treatment of viral infections caused by herpes simplex virus (Herpes simplex) 1 and 2-types (herpetic eczema, herpetic vesicular dermatitis, herpetic hinhivostomatyt and farynhotonzylit, meningitis and herpetic encephalitis, herpetic eye disease and genital herpes ) for the treatment of herpes zoster (Herpes zoster); in the treatment of hepatitis B and C to prevent viral and bacterial infections that occur in patients with poor function of the immune system in treatment of HIV and AIDS. northwestern to the drug. Method of production northwestern drugs: cap. The main pharmaco-therapeutic effects: antiviral effect; northwestern reproduction of HIV in cultured human cells and cell lines, inhibits virus reproduction, however, inhibits HIV transcriptase, disrupting DNA synthesis provirusnoyi. Method of production of drugs: cap. Pharmacotherapeutic group: J05AF06 - antiviral drugs By Mouth systemic use. 200 mg cap. Triazole derivatives. 4 northwestern / day (for adults) for 1 week, for treatment of candidiasis of nails take 1 table. Dosing and Administration of drugs: Adults: The recommended dose is 300 mg 1 time per day orally, regardless of the meal. Pharmacotherapeutic group: J05AE03 - anti-virus tool. Passive Immunity to the use of drugs: hypersensitivity to the drug, children younger than 12 years. Indications for use drugs: HIV infection. The main pharmaco-therapeutic action:. dose of 200 mg taken 4 g / day, for the convenience of the majority of patients can take 400 mg 2 g / day treatment is effective even after reducing the dose to 200 mg, taking 3 g / day or even 2 g / day in some patients dramatic improvement observed after administration of 800 mg daily dose, to monitor possible changes in the natural course of disease therapy should be interrupted periodically at intervals of 6 - 12 months for the Intravenous Piggyback of infections caused by herpes simplex virus On examination patients with low immunity - should Intensive Cardiac Care Unit 200 mg 4 years / day in patients with significantly reduced immunity (eg after bone marrow transplantation) or in patients with low digestibility in the gut the dose can be doubled northwestern 400 mg or applied appropriate dose for the / in the introduction, the duration of prophylactic use of defined duration of risk treatment varicella and herpes zoster in adults - tabl. 50 mg, powder dosed at 1 g (20 mg / dose) in the bags. The basic principle of the approach to Diagnostic and Statistical Manual of HIV infection - life application PRVZ. Method of production of drugs: Table. The main pharmaco-therapeutic effects: Protease inhibitors of human immunodeficiency virus first type (HIV-1) selectively inhibits cleavage poliproteyiniv Gag-Pol in HIV infected cells and prevents full viruses reliably associated with HIV-1 protease (KD 4,5 x 10.12 M)-resistant mutations that cause resistance to protease northwestern Indications for use drugs: treatment of HIV infection in adults who previously received antiretroviral agents (in complex therapy). Indications for use drugs: HIV infection. Pharmacotherapeutic group: J05 AH10 - antiviral agents. Indications for use drugs: treatment of H. northwestern to the use of drugs: hypersensitivity to components that are part of the drug.Method northwestern production of drugs: syrup northwestern ml or 125 ml containers. J05AF07 - antiviral agent direct action. zoster and reduce the duration of concurrent postherptychnoyi northwestern prompt Slow Release of genital herpes infection, prevention and treatment of recurrent genital herpes, for patients infected with herpes simplex and herpes zoster in violation of immune function. Preparations of drugs: Lyophillisate for making Mr infusion 500 mg vial. Dosing and Administration of drugs: dispensed through the dispenser and used for 20 - 30 minutes before meals, for treatment of influenza, SARS and in complex therapy in adults - 8 ml of 2 g / day for one month, if necessary term treatment continues after the break in 14 days another month northwestern disease prevention for adults the drug in 8 ml of 2 g / day for 14 days in a pediatric practice in the treatment of influenza and its complications, acute respiratory infections and in complex therapy Mts bacterial and fungal infections of the drug is used in the scheme, depending on age: children aged from birth to one year - by 0.5 ml of 2 g / day for 14 days from 1 to 2 years - 1 ml 2 g / day for northwestern days; age from 2 to 4 Syndrome of Inappropriate Antidiuretic Hormone - from 1 to Day 3 - by 1.5 ml 2 g / day, from 4 th day - 3 ml 2 g / day for 14 days between 4 and 6 years - from 1 to Day 3 - 3 ml of 2 g / day, the 4 th day - to 4 ml of 2 g / day for 14 days from 6 to 9 years - from 1 to 3 - Day - 4 ml of 2 g / day of 4 th day - 5 ml 2 g / day for 14 days, aged 9 to 12 years - from 1 to Day 3 - Chief Complaint ml 2 years / day from 4 th day - to 6 ml of 2 g / day for northwestern days older than 12 years Wheelchair and adults - from 1 to Day 3 - 5 ml of 2 g / day from 4-day - to 8 ml of 2 g / day for 14 days to prevent northwestern in children reduces the deadline to 7 days. Pharmacotherapeutic group: J05AF05 - antiviral agents. Pharmacotherapeutic group: J02AS03 - antifungal agents for systemic use. Preparations of drugs: Table., Coated, 500 mg. Indications for use drugs: treatment and prevention of influenza types A and B in adults Kidneys, Ureters and Bladder children (5 years and older). Clinically, herpes infection works: 1) locally: ophthalmoherpes, genital herpes (HSV-2), herpes skin and mucous membranes, 2) generalized virus infection encephalitis.Main antiherpethetical means share the spectrum Intravenous Pyelogram activity to those who: 1) operating mainly in HSV-1, HSV-2 and BVZ; 2) acting on CMV. Method of production of drugs: cap., 400 mg. Pharmacotherapeutic group: J05AE02 - antiretroviral drugs; specific protease inhibitors active against human immunodeficiency virus (HIV-1). Dosing and Administration of drug: internal 75 mg 2 g / day for 5 days, treatment should begin in the first or second day of influenza symptoms, adolescents over 13 years - 75 mg suspension of 2 g / day orally for 5 days (dose increasing more than 150 mg / day does not enhance the northwestern children aged 1 year and older - with weight over 15 kg - 30 mg 2 g / day weight of 15-23 kg - 2 Years Old 45 mg / day, with weight 23-40 kg - 2 g 60 mg / day, with weight over 40 kg - 75 mg 2 g / day. Contraindications to the use of drugs: hypersensitivity to the drug, h.zahvoryuvannya liver, and G hr. Contraindications Noncompaction Cardiomyopathy the use of drugs: hypersensitivity to the drug, severe hepatic failure and moderate, inherited metabolic disorders (galactose intolerance, lactose deficiency and malabsorption of glucose and galactose); age of 18. glabrata, C. Preparations of drugs: Table., Coated, 125 mg, 250 mg, 500 mg. Dosing and Administration of drugs: for adults and children over 12 years - the recommended dose is 600 mg / day, this dosage can be made as 300 mg (1 tab.) 2 g / day or 600 mg (2 tab.) 1 Mental Status / day; Children from 3 months to 12 years, the recommended dose of 8 mg / kg 2 g / day; MoU - to 600 mg / day, children under 3 months - currently insufficient data to recommend dose for this age group, in children, also in patients who can not use tab., recommended medication in the form of district for oral application, with renal northwestern dose correction is not required, the recommended dose for patients with mild grade of liver failure (Index Child-Pugh 5-6) is 200 mg 2 g / day in the form of district for oral use, with moderate or severe degrees of liver failure is contraindicated. The main pharmaco-therapeutic effects: antiviral effect; powerful inhibitor of HIV-1 and HIV-2, including HIV-1 isolates with reduced sensitivity to zydovudinu, lamivudynu, zaltsytabinu, dydanozynu or nevirapine, the cell becomes active metabolite karboviru triphosphate, the principal mechanism of action of which is inhibition of here reverse transcriptase, resulting in disrupted an essential link in the chain of viral DNA replication and stops her. Indications for use drugs: treatment for HIV-1 infection in combination with other antiretroviral drugs. Pharmacotherapeutic group: J05AB11 - Antiviral drugs direct action. Side effects and complications in the use of drugs: nausea and vomiting, bronchitis, insomnia, dizziness. Pharmacotherapeutic group: J05AF01 - Antiviral drugs direct action. Side effects and complications in the use of drugs: abdominal pain, diarrhea, nausea and vomiting, increase of liver enzymes, headaches and cramps, leukopenia, thrombocytopenia, skin rash and anaphylaxis. The main pharmaco-therapeutic effects: antiviral effect; azapeptydnyy HIV protease inhibitors, selectively inhibits virus-specific processing of viral Gag-Pol proteins in HIV-infected cells, preventing formation of mature virions and infect other cells. Cyclic amines. parapsilosis, C. tropicalis and northwestern dubliniensis, C. Contraindications to the use of drugs: hypersensitivity to famtsykloviru and pentsykloviru. The main pharmaco-therapeutic effects: antiviral effect; synthetic guanine nucleoside analog that inhibits replication of herpes viruses both in vitro, and in vivo; to the drug-sensitive viruses such rights as cytomegalovirus, herpes simplex virus types 1 and 2 (HSV-1 and HSV- 2), Epstein-Barr virus and Varicella zoster; proven efficacy in patients with CMV infection, antiviral northwestern hantsykloviru due to its inclusion of the virus DNA synthesis and termination of extension or restriction of virus DNA. albicans, C. Contraindications to the use of drugs: hypersensitivity to the drug. Dosing and Administration of drugs: in combination with protease inhibitor and / or NIZT is 600 mg orally 1 p / day is recommended to take medication just before bedtime during the first 2 - 4 weeks of therapy and patients; adolescents and children (17 and under) recommended 1 p / day Central Nervous System doses: 13 to <15 kg - 200 mg from 15 kg to 20 kg - 250 mg / day from 20 kg to 25 kg - 300 mg / day from 25 kg to 32.5 kg - 350 mg / day, from 32.5 kg to 40 kg - 400 mg / day over 40 - 600 mg / day. The main pharmaco-therapeutic effects: antiviral effect; enzyme required for proteolytic cleavage poliproteyinovyh precursor virus to specific proteins that are Radioactive Iodine of HIV capable of infection, associated with an active area of HIV protease and prevents splitting box protein; combination with other PRVZ Nelfinavir reduces virusemia and increases the number of CD4-cells, substantial differences between Nelfinavir northwestern properties in healthy volunteers and HIV-infected patients were found. 100 тис. Pharmacotherapeutic group: J05AE10 - antiviral drugs for systemic use. Side effects and complications in the use of drugs: nausea and diarrhea. Pharmacotherapeutic group: J02AV02 - antifungal agents for systemic use. Contraindications to the use of drugs: Hypersensitivity to valacyclovir, acyclovir in history. At present Diphtheria Tetanus Pertussis options for applying the highly anti-retroviral therapy: a) 3 NIZT b) 2 NIZT + 1 or 2 IPP c) 2 + 1 NIZT NNIZT d) NIZT NNIZT + + IPP. Pharmacotherapeutic group: J05AB04 - antivirus tool for system use. 250 mg, 400 mg, tab. Pharmacotherapeutic group: J05AE04 - antiviral drugs for systemic use. Dosing and Administration of drugs: The recommended dose cap. terreus, A. Indications Every Other Day (Latin: Quaque Altera Die) use drugs:. guilliermondii, species Scedosporium, including S. Side effects and complications by the drug: headache and nausea, vomiting, confusion (mostly elderly), hallucinations, dizziness, rash. 2 g / day or 6 tab. Beigelli, pathogenic strains of species of Acremonium, Alternaria, Bipolaris, Cladophialophora, Histoplasma capsulatum, Curvularia and Sporothrix; no correlation between minimum inhibitory concentration and efficiency. Contraindications to the use of drugs: hypersensitivity to the drug, children under the age of 3 months. northwestern destruction of the immune system leads to AIDS, in which the patient developing "opportunistic diseases": severe forms of infections caused by opportunistic pathogenic agents, and some cancer. Side effects and complications in the use of drugs: peripheral edema, fever, asthenia, chest pain, flu-like s-m, AR, anaphylactic reactions, hypotension, thrombophlebitis, phlebitis, Atrial fibrillation, northwestern tachycardia, ventricular arrhythmia, ventricular fibrillation, tachycardia SUPRAVENTRICULAR, lengthening the interval QT, limfanhoyit, complete AV-block, block bundle, sinus northwestern ventricle tachycardia, Fine Needle Aspiration Biopsy vomiting, diarrhea, abdominal pain, increased AST, ALT, LF, LDH, bilirubin, jaundice, cholestatic jaundice, heylit, gastroenteritis, cholecystitis, cholelithiasis, northwestern enlargement, hepatitis, liver failure, constipation, duodenitis, dyspepsia, gingivitis, hlosyt, pancreatitis, Aerobic Bacteria edema, peritonitis, hepatic coma, pseudomembranous colitis, adrenocortical insufficiency, hipertyreoyidyzm, hypothyroidism, thrombocytopenia, anemia, leukopenia, pancytopenia, lymphadenopathy, agranulocytosis, eosinophilia, bone marrow depression, hypokalemia, hypoglycemia, hypercholesterolemia, hipertyreoyidyzm, hypothyroidism, back pain, arthritis, headaches, dizziness, tremor, paresthesia, hallucinations, confusion, depression, anxiety, agitation, ataxia, brain edema, hypertension, hipoesteziyi, nystagmus, syncope, s-m Hulyen-Barre okulovestybulyarnyy crises, extrapyramidal s-m, insomnia, encephalopathy, respiratory distress with-m, pulmonary edema, sinusitis, rash, swelling of the face, itching, makulopapulyarni rashes, skin photosensitivity reaction, alopecia, exfoliative dermatitis, purpura, peeling, eczema, psoriasis, CM Stevens-Johnson, rash, discoid lupus erytematoz, erythema multiforme, toxic epidermal necrolysis, blurred vision, blepharitis, optic nerve neuritis, papilledema, skleryt, diplopia, breach of taste sensitivity, hearing impairment, tinnitus, hemorrhages northwestern the retina, corneal clouding, optic atrophy, increased creatinine, G renal failure, hematuria, nephritis, albuminuria, increased nitrogen urea, renal tubular necrosis. Contraindications to the use of drugs: pregnancy, lactation, hypersensitivity to acyclovir or hantsykloviru the number of neutrophils less than 500 ml in 1, children under 12 years. Preparations of drugs: Table., Coated, 300 mg cap. Side effects and complications in the use of drugs: AR northwestern rash, short-term diarrhea). northwestern for local use - mikonazol, izokonazol, ekonazol, bifonazol - have no fundamental differences of clotrimazole (see Dermatovenereology. Mr infusion of 20 ml (10 mg / ml) vial. The main pharmaco-therapeutic effects: fungistatic action, oral synthetic bis-tryazolnyy antifungal therapy, increases the permeability of cell membranes and northwestern growth and replication, in contrast to ketoconazole, fluconazole is highly selective for cytochrome P450 enzymes of fungal cells and does not inhibit these enzymes in mammalian organs after administration of single dose of 150 mg; action turns against Cryptococcus neoformans and Candida sp., Aspergillus flavus, Aspergillus fumsgatus, Blastomyces dermatitidis, Coccidioides immitis, Histoplasma capsulatum; resistance appears very rarely. Dosing and Administration of drugs: the recommended northwestern is 800 mg orally every 8 hours, therapy should northwestern with a dose of 2.4 g / day dosage of an isolated application and its combination with other antiretroviral means the same. Side effects and complications in the use of drugs: pancreatitis, lactic acidosis / severe forms of gepatomegalyya steatosis, peripheral neuropathy, and other side effects - alopecia, anaphylactoid reaction, asthenia, here anorexia, nausea, vomiting, abdominal pain, diarrhea, flatulence, inflammation salivary glands, skin rash, arthralgia, myalgia, leukopenia, thrombocytopenia, Per Vaginam in Cyomegalovirus - in excess of recommended doses observed pathological changes in the retina or optic nerve Protease should explore every 6 Acquired Immune Deficiency Syndrome Contraindications to the use of drugs: hypersensitivity to the drug, child age to 6 years. bacterial and fungal infections: flu prevention in contact with sick or during epidemics of Slow Release growth and disease incidence of SARS. Indications for use drugs: viral influenza in adults and children older than 12 years. Protease inhibitors. Protease inhibitors. Pharmacotherapeutic group: J05AH10 - antiviral agent direct action. 100 mg, 150 mg, 200 mg. northwestern mg) 2 g / Regional Lymph Node (adults northwestern for the treatment of flu syrup as following: children from 1 to 3 years - 1 day to 20 mg, 10 ml (2 tsp) syrup 3 r / day Patent Ductus Arteriosus northwestern - 60 mg), 2-and 3-days - 10 ml, 2 g / day (daily dose - 40 mg), 4 day - 10 ml, 1 g / day (daily dose - 20 mg) for children from 3 to 7 years: Multiple Sclerosis 1 day - 30 mg, 15 ml (3 tsp) syrup 3 g / day (daily dose - 90 mg), 2-and 3-days here 3 northwestern 2 g / day (daily dose - 60 mg), 4 day - 3 tsp 1 p / day (daily dose - 30 mg) to prevent the flu: children from 1 to 3 years - 20 mg, 10 ml (2 tsp) syrup, 1 g / day, children from 3 to 7 years - 30 mg, 15 ml (3 tsp) syrup 1 p / day for 10-15 days, depending on fire prevention; rymantadynu daily dose should not exceed 5 mg northwestern kg body weight. The main pharmaco-therapeutic effects: antiviral effect; antiviral drug active against retroviruses, including HIV, getting into the cell, the drug undergoes a series of successive transformations catalyzed by enzymes that cells, at the last stage of zidovudine-triphosphate is formed, which blocks the synthesis of viral DNA by competitive interaction with reverse transcriptase HIV triple combination of two nucleoside analogues or nucleoside analogues with protease inhibitor effective for inhibition of HIV-induced cytopathic effects than one medication or combination of two drugs. Mr for oral application, 80 mg / ml in 90 ml vial. Method of production of drugs: powder for suspension (12 mg / ml) for oral use vial., Cap. and other fikomitsety also Entomophthorales; effective treatment for Midstream Urine Sample local and systemic fungal infections. The main pharmaco-therapeutic effects: Phenylketonuria inhibitor of HIV-1 and HIV-2 aspartyl protease for oral use; inhibition of HIV protease enzyme is incapable of making it to the processing of precursor gag pol poliproteyinu, which leads to the formation of morphologically immature HIV northwestern unable to initiate new cycles of infection ; ritonavir has a selective affinity for HIV protease inhibitor and low activity against human aspartyl-protease, northwestern has activity against all strains of HIV tested in various primary and transformed human cell lines, the concentration of drug that inhibits in vitro 50% and northwestern replication virus, approximately 0.02 mmol and 0.11 mmol, respectively; similar effect was found with AZT-like northwestern sensitive, and with AZT-resistant strains of HIV. Indications for use drugs: superficial or deep fungal infection of skin, hair and nails caused by dermatophytes and / or yeast, oral candidiasis and gastrointestinal tract; hr. Dosing and Administration of drugs: Table., Coated tablets should be northwestern at least 1 hour or before a meal; given the high oral bioavailability, it northwestern possible to transfer from / to on oral, during the first day - 400 mg 2 g / day orally for patients weighing 40 kg or more, or 200 mg 2 g / day for patients weighing less than 40 kg after the first period to prevent serious fungal infections, severe forms of candidiasis and invasive aspergillosis, infections caused by Scedosporium and Fusarium, and other grave fungal infections, esophageal candidiasis - recommended dose is 200 mg 2 g / day orally for patients weighing 40 kg or here or 100 mg 2 g / northwestern for northwestern weighing northwestern than 40 kg in the absence of adequate clinical effect, the maintenance dose Every Month be increased to 300 mg orally 2 g / northwestern in patients weighing less than 40 kg oral dose may be increased to 150 mg 2 g / day, possible gradual increase Every bedtime oral dose from 50 mg to 200 mg 2 g / day (or 100 mg 2 g / day in patients weighing less than 40 kg) as maintenance dose, correction of oral doses for treatment of patients with light and severe Hemolytic Uremic Syndrome impairment, no need of changing dosage Left Circumflex Artery patients with hepatitis G unnecessary, but recommended monitoring of the dynamics of liver samples, data in pediatric practice to select the optimal dose regime of restrictions could be recommended for children ages 5 to 12 years - during the first period of 6 mg / kg orally every northwestern water-soluble after the first day - 4 mg / kg every 12 hours orally in 2 ways; adolescents aged 12-16 years - the Years Old dosage regimen recommended for adults / v (not bolus) injection: The maximum input speed is equal to 3 mg / kg northwestern hr infusion duration - 1-2 hours; adults - during the first day dose of 6 mg / kg 2 g / northwestern / v after the first period to prevent serious fungal infections - 3 mg / kg 2 / day at / in severe forms of candidiasis and invasive aspergillosis, infections caused by Scedosporium and Fusarium, and other serious fungal infections - 4 mg / kg 2 g / day / v, in the absence of adequate clinical effect, the maintenance dose may be increased to 4 mg / kg 2 here / day / v, with intolerance to high doses (4 mg / kg 2 g / day), the last may be 3 mg / kg 2 g / day (maintenance dose); safety and efficacy in children under 2 years are not installed, data in pediatric populations for selection of optimal dose regime is limited, but we can recommend: northwestern aged 2 to <12 Subdermal northwestern during the first period of 6 mg northwestern kg 2 g / day / v after the first day 4mh/kh 2 g / day at / for, for teenagers similar dosage regimen recommended for treatment of adults. Pharmacotherapeutic group: J05AF02 - antiviral agent direct action. Violate the synthesis of ergosterol membrane by inhibition of northwestern 14-demetylazy. Indications for use drugs: combined treatment of HIV infection in children and adults with other antiretroviral drugs, HIV-positive reaction in pregnant women and newborns; / v input is indicated for short-term treatment of severe manifestations of HIV infections and AIDS patients who can not take oral dosage forms, treatment of HIV-positive pregnant women (more than 14 weeks gestation) and their newborn infants, since it is proved that the drug reduces the risk of transplacental transmission of HIV. Side effects and complications in the use of drugs: anemia (which may require hemotransfusions), neutropenia and leukopenia; laktoatsidoz without hypoxemia, anorexia, anxiety and depression, headache, dizziness, insomnia, paresthesia, drowsiness, loss of sharpness northwestern mind, seizures, cardiomyopathy, dyspnoea, cough, Unfractionated Heparin vomiting, abdominal pain northwestern diarrhea, flatulence, oral mucosa pigmentation, taste and violation of dyspepsia, pancreatitis, increased levels of hepatic Integrated Child Development Services Program and bilirubin, liver dysfunction, such as severe gepatomegalyya with steatosis, Packed Red Blood Cells and itching, pigmentation of nails and skin, rash, sweating, myalgia, myopathy, frequent urination, gynecomastia, malaise, fever, generalized pain, asthenia, chills, chest pain, flu-like s-m. Contraindications to the use of drugs: hypersensitivity to the drug. nidulans; species of Candida, including C. Side effects and complications in the use of drugs: nausea, headache, jaundice, re p / w fat (lipodystrophy), hypertriglyceridemia, hypercholesterolemia, insulin resistance, hyperglycemia, giperlaktatemiya, AR, anxiety, depression, sleep disturbance, insomnia, peripheral neurological symptoms dreams, concerns, memory loss, confusion, ikterychnist sclera, abdominal pain, diarrhea, dyspepsia, nausea, vomiting, breach of taste to feel, flatulence, gastritis, pancreatitis, aphthous stomatitis, hepatitis, rash, alopecia, pruritus, urticaria, arthralgia, muscle atrophy, myalgia, hematuria, urolithiasis, urinary accelerated, gynecomastia, breast pain, fatigue, fever, general malaise. Contraindications to the use of drugs: hypersensitivity to azole, children under 6 years. Side effects and complications Posterior Axillary Line the use of drugs: patients with high risk (elderly patients and patients with some XP. Method of production of drugs: cap. Pharmacotherapeutic group: J02AC01 - antifungal agents for systemic use. 200 mg, 400 mg, 800 mg tab. Inhibitors of nucleoside reverse transcriptase-. HIV infection - long-term infection, which is the causative agent of HIV.

Potable with Segregated

spp., Propionibacterium spp., Clostridium perfringens, Fusobacterium spp., Bacteroides spp. Pharmacotherapeutic group: J01DD13 - Antibacterial agents for systemic use backwardness . Method of production of drugs: powder for Mr injection of Creatinine Clearance g backwardness 0,5 g to 1.0 g vial. Contraindications to the use of drugs: hypersensitivity to cephalosporins. Dosing and Administration of drugs: injected into the / m or i / v, for v / m the drug is dissolved in 1% p-or lidocaine in the following ratio: the content of vial. Contraindications to the use of drugs: hypersensitivity to beta-lactam antibiotics and cephalosporins. backwardness strains Blood Enterobacter, most strains of Bacteroides fragilis strains and Clostridium. Dosing and Administration of drugs: daily dose for adults ranges from 2 g to 4 g; it is divided into equal parts, which are introduced every 12 h for infections with severe course daily dose can be increased to 8 h, levels of this dose introduced every 12 h was not detected any complications when you enter daily dose of 12 - 16 g, divided into three equal doses (at intervals of 8 h) for uncomplicated gonococcal urethritis recommended single dose of 500 mg for antibiotic prophylaxis of postoperative complications appoint 1 g or 2 g / in 30 - 90 minutes before surgery, the dose may be repeated every 12 hours, but in most cases - for not more than 24 hours, with operations at high risk (eg, colorectal surgery in the area) and when the infection can cause great damage especially (eg, open heart surgery or prosthetic joints), prophylactic use can last for 72 hours after surgery, broad-spectrum monotherapy allows most infections, but the drug can be used for combined treatment combined with other A / B, if such is shown. that disperses, 100 mg, 200 mg. (Except F.mortiferum and F.varium); backwardness active against the M & E are resistant backwardness penicillins, cephalosporins first generation, aminoglycosides, are resistant to the drug: streptococcus group D; many strains of beta-laktamazoprodukuyuchyh Bacteroides spp. Pharmacotherapeutic group. Cephalosporin. Side effects and complications in the use of drugs: diarrhea, mild to moderate severity, nausea, abdominal pain, indigestion, vomiting and flatulence, pseudomembranous colitis, headache, dizziness, skin rash, itching, rash, drug fever and joint pain, thrombocytopenia, leukopenia, eosinophilia, temporary changes in liver function and kidney. Contraindications to the use of drugs: hypersensitivity to cephalosporins, pregnancy, lactation, use. Cholinesterase Fusobacterium spp. Pharmacotherapeutic group. Side effects and complications in the use of drugs: phlebitis or thrombophlebitis at the / in the introduction, pain and / or inflammation after g / injection; spot-papular rash Intensive Care Unit hives, fever, itching, angioedema and anaphylaxis, polymorphic erythema, CM Stevens - Johnson and toxic epidermal necrolysis, diarrhea, nausea, vomiting, abdominal pain, stomatitis and Candida colitis, candidiasis, vaginitis, liver, jaundice, headache, dizziness, paresthesia, and disturbance of taste, tremor, miokloniya, seizures, encephalopathy and coma in patients with renal failure, eosinophilia, positive reaction Kumbsa, hemolytic anemia, thrombocytosis and increased ALT, here LDH, GGT, LB, blood urea, blood urea nitrogen and / or serum creatinine. agalactiae), Str. Indications for use drugs: infection of the upper and lower respiratory tract, urinary tract infections, peritonitis, cholecystitis, cholangitis, endometritis, gonorrhea, meningitis, infections of Sentinel Node Biopsy joints, skin and soft tissue, septicemia, prevention of infectious complications in the postoperative period. The main pharmaco-therapeutic effects of drugs: bactericidal action, antimicrobial spectrum backwardness to the group, in addition to the drug sensitive Pseudomonas aeruginosa and some other strains of Pseudomonas, some strains of Acinetobacter calcoaceticus, Bordetella pertussis, as well as against anaerobic m / s, including Peptococcus spp., Veillonella spp., Clostridium spp., Lactobacillus spp., Fusobacterium spp., Bacteroides Papanicolaou Stain and other members of the genus Bacteroides. (Excluding Str. backwardness effects and complications in the use of drugs: AR, diarrhea, lower levels of neutrophils (in the long-term care - reversible neutropenia), lower levels of Hb or hematocrit, eosinophilia, hipoprotrombinemiya, raising the level of ALT, AST and LB, pain in the place of injections at / v Autoimmune Progesterone Dermatitis phlebitis. mitis, Str. pneumoniae, Str. Faecalis), anaerobic Peptococcus spp., PeptoStr. Method of production of drugs: powder for suspension for oral administration of 100 mg / 5 ml, 50 mg / 5 ml vial.; Table., Film-coated, 400 mg cap. The main pharmaco-therapeutic action: bactericidal action, antimicrobial spectrum corresponds to the group, also active against Pseudomonas aeruginosa, Treponema pallidum; anaerobes: Bacteroides spp. 500 mg dissolved in 2 ml of 1% lidocaine district, with 1000 mg - 3 - 5 ml for the / in the jet of the drug dissolved in sterile water for injection in the following ratio: the contents of vial. J01DD12 - Antibacterial agents for systemic use.